Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Houston Thompson

Showing results (211-220 of 374) with videos related to

Pageof 38
Sort By:
The Journal of Urology|September 6, 2022
Cost-effectiveness of Adjuvant Pembrolizumab After Nephrectomy for High-risk Renal Cell Carcinoma: Insights for Patient Selection From a Markov ModelVidit Sharma, Kevin M Wymer, Daniel D Joyce, et al.
Scandinavian Journal of Urology|January 3, 2019
Heterogeneity of risk within Gleason 4 + 4, 4 + 5 and 5 + 4 prostate cancerMarco Moschini, Vidit Sharma, Matteo Soligo, et al.
Urology|July 30, 2013
Percutaneous renal cryoablation in obese and morbidly obese patientsGrant D Schmit, R Houston Thompson, Stephen A Boorjian, et al.
Urologic Oncology|November 26, 2019
The association of anxiety and depression with perioperative and oncologic outcomes among patients with clear cell renal cell carcinoma undergoing nephrectomyVignesh T Packiam, Mark D Tyson Ii, Matvey Tsivian, et al.
The Journal of Urology|April 12, 2017
Severity of Preoperative Proteinuria is a Risk Factor for Overall Mortality in Patients Undergoing NephrectomyDavid Y Yang, R Houston Thompson, Harras B Zaid, et al.
Cancer|June 24, 2005
Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressivenessShomik Sengupta, Christine M Lohse, Bradley C Leibovich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 2011
Identification of a soluble form of B7-H1 that retains immunosuppressive activity and is associated with aggressive renal cell carcinomaXavier Frigola, Brant A Inman, Christine M Lohse, et al.
World Journal of Urology|November 5, 2018
A risk-stratified approach to neoadjuvant chemotherapy in muscle-invasive bladder cancer: implications for patients classified with low-risk diseaseTimothy D Lyon, Igor Frank, Vidit Sharma, et al.
The Journal of Urology|November 6, 2012
Percutaneous renal cryoablation after partial nephrectomy: technical feasibility, complications and outcomesRyan M Hegg, Grant D Schmit, Stephen A Boorjian, et al.
The Journal of Urology|September 28, 2011
Contemporary trends in nephrectomy for renal cell carcinoma in the United States: results from a population based cohortSimon P Kim, Nilay D Shah, Christopher J Weight, et al.
Pageof 38

Showing results (211-220 of 374) with videos related to

Sort By:
Pageof 38
The Journal of Urology|September 6, 2022
Cost-effectiveness of Adjuvant Pembrolizumab After Nephrectomy for High-risk Renal Cell Carcinoma: Insights for Patient Selection From a Markov ModelVidit Sharma, Kevin M Wymer, Daniel D Joyce, et al.
Scandinavian Journal of Urology|January 3, 2019
Heterogeneity of risk within Gleason 4 + 4, 4 + 5 and 5 + 4 prostate cancerMarco Moschini, Vidit Sharma, Matteo Soligo, et al.
Urology|July 30, 2013
Percutaneous renal cryoablation in obese and morbidly obese patientsGrant D Schmit, R Houston Thompson, Stephen A Boorjian, et al.
Urologic Oncology|November 26, 2019
The association of anxiety and depression with perioperative and oncologic outcomes among patients with clear cell renal cell carcinoma undergoing nephrectomyVignesh T Packiam, Mark D Tyson Ii, Matvey Tsivian, et al.
The Journal of Urology|April 12, 2017
Severity of Preoperative Proteinuria is a Risk Factor for Overall Mortality in Patients Undergoing NephrectomyDavid Y Yang, R Houston Thompson, Harras B Zaid, et al.
Cancer|June 24, 2005
Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressivenessShomik Sengupta, Christine M Lohse, Bradley C Leibovich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 2011
Identification of a soluble form of B7-H1 that retains immunosuppressive activity and is associated with aggressive renal cell carcinomaXavier Frigola, Brant A Inman, Christine M Lohse, et al.
World Journal of Urology|November 5, 2018
A risk-stratified approach to neoadjuvant chemotherapy in muscle-invasive bladder cancer: implications for patients classified with low-risk diseaseTimothy D Lyon, Igor Frank, Vidit Sharma, et al.
The Journal of Urology|November 6, 2012
Percutaneous renal cryoablation after partial nephrectomy: technical feasibility, complications and outcomesRyan M Hegg, Grant D Schmit, Stephen A Boorjian, et al.
The Journal of Urology|September 28, 2011
Contemporary trends in nephrectomy for renal cell carcinoma in the United States: results from a population based cohortSimon P Kim, Nilay D Shah, Christopher J Weight, et al.
Pageof 38